Acquired Company

Lilly completed the acquisition of Prevail Therapeutics Inc. on 1/22/2021.

Show more

Biological Product (except Diagnostic) Manufacturing

Manufacturing

Start AI Chat

Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$23.00

Open

$23.00

Volume

N/A

Day Range

$23.00 - $23.00

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

0.00%

Institutional Own.

0.00%

Qtr Updated

09/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date